GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (LTS:0I7E) » Definitions » Cyclically Adjusted PB Ratio

DaVita (LTS:0I7E) Cyclically Adjusted PB Ratio : 6.14 (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is DaVita Cyclically Adjusted PB Ratio?

As of today (2024-05-25), DaVita's current share price is $137.615. DaVita's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $22.43. DaVita's Cyclically Adjusted PB Ratio for today is 6.14.

The historical rank and industry rank for DaVita's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0I7E' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.13   Med: 4.35   Max: 7.76
Current: 6.17

During the past years, DaVita's highest Cyclically Adjusted PB Ratio was 7.76. The lowest was 2.13. And the median was 4.35.

LTS:0I7E's Cyclically Adjusted PB Ratio is ranked worse than
82.02% of 317 companies
in the Healthcare Providers & Services industry
Industry Median: 1.99 vs LTS:0I7E: 6.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DaVita's adjusted book value per share data for the three months ended in Mar. 2024 was $10.558. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $22.43 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita Cyclically Adjusted PB Ratio Historical Data

The historical data trend for DaVita's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted PB Ratio Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.54 5.46 5.00 3.22 4.66

DaVita Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.50 4.35 4.12 4.66 6.15

Competitive Comparison of DaVita's Cyclically Adjusted PB Ratio

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PB Ratio falls into.



DaVita Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

DaVita's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=137.615/22.43
=6.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DaVita's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.558/131.7762*131.7762
=10.558

Current CPI (Mar. 2024) = 131.7762.

DaVita Quarterly Data

Book Value per Share CPI Adj_Book
201406 22.284 100.560 29.202
201409 23.153 100.428 30.380
201412 23.977 99.070 31.893
201503 23.116 99.621 30.577
201506 23.887 100.684 31.264
201509 23.650 100.392 31.044
201512 23.221 99.792 30.663
201603 22.791 100.470 29.892
201606 22.938 101.688 29.725
201609 24.464 101.861 31.649
201612 23.891 101.863 30.907
201703 26.413 102.862 33.838
201706 26.592 103.349 33.906
201709 25.284 104.136 31.995
201712 25.704 104.011 32.566
201803 25.667 105.290 32.124
201806 25.051 106.317 31.050
201809 23.042 106.507 28.509
201812 22.258 105.998 27.671
201903 23.290 107.251 28.616
201906 24.620 108.070 30.021
201909 17.317 108.329 21.065
201912 16.953 108.420 20.605
202003 15.992 108.902 19.351
202006 17.657 108.767 21.392
202009 13.840 109.815 16.608
202012 12.586 109.897 15.092
202103 11.344 111.754 13.376
202106 12.097 114.631 13.906
202109 11.145 115.734 12.690
202112 7.766 117.630 8.700
202203 8.860 121.301 9.625
202206 6.559 125.017 6.914
202209 5.912 125.227 6.221
202212 7.879 125.222 8.291
202303 9.106 127.348 9.423
202306 11.148 128.729 11.412
202309 13.128 129.860 13.322
202312 11.890 129.419 12.107
202403 10.558 131.776 10.558

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DaVita  (LTS:0I7E) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


DaVita Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (LTS:0I7E) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (LTS:0I7E) Headlines

No Headlines